Laval, QC – The health research funding organizations of Quebec (the Fonds de la recherche en sant du Qubec, FRSQ), France (the Institut national de la sant et de la recherche mdicale, Inserm) and Canada (the Canadian Institutes of Health Research’s Institute of Neurosciences, Mental Health and Addiction, and Institute of Aging) have signed a co-operation agreement on Alzheimer’s disease research.
The agreement provides for the funding of research projects that reflect specific objectives linked directly to the diagnosis, treatment or management of patients with Alzheimer’s disease or related diseases. The partners say the projects must be significant and involve specialists in various disciplines and from various university and hospital institutions forming multidisciplinary consortia. The consortia must be structured in such a way as to contribute original added value that each country would be unable to achieve alone.
The partners of the FRSQ in this agreement are the Ministre du Dveloppement conomique, de l’Innovation et de l’Exportation and the Ministre de la Sant et des Services sociaux.